DelveInsight’s “Sialorhhea Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Sialorhhea, historical and forecasted epidemiology as well as the Sialorhhea market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Sialorhhea Key Highlights
Key Companies working in the Sialorhhea market include Merz Pharma, Proveca, and many others
Key Therapies included in the Sialorhhea market include Hyoscine, Glycopyrrolate, Myobloc, and many others
Sialorhhea Overview
Sialorrhea, also known as hypersalivation or excessive drooling, literally means excessive saliva flow. Sialorrhea can be classified as anterior and posterior; both can occur separately or simultaneously. Posterior sialorrhea is the flowing of saliva from the tongue to the pharynx. Anterior sialorrhea results in salivary incontinence or involuntary spillage of saliva over the lower lip, known as drooling. Sialorrhea (drooling or excessive salivation) is a common problem in neurologically impaired children (i.e., those with mental retardation or cerebral palsy) and in adults who have Parkinson’s disease or have had a stroke. It is most commonly caused by poor oral and facial muscle control.
Sialorhhea Epidemiology Insights
The actual prevalence rate for patients who drool is unknown. However, 0.5-0.7% of all children born are diagnosed with cerebral palsy. From 10-37% of patients with cerebral palsy have been reported to have difficulty with drooling because of neurologic impairment.
Click here to learn more about the Sialorhhea Market Landscape
The Report Covers the Sialorhhea Epidemiology Segmented by:
Sialorhhea prevalent cases
Sialorhhea incident cases
Sialorhhea treatment cases
Sialorhhea diagnosed cases
Sialorhhea Market Outlook
The Sialorrhea market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Sialorrhea market trends by analyzing the impact of current Sialorrhea therapies on the market, unmet needs, drivers and barriers, and demand for better technology. This segment gives a thorough detail of the Sialorrhea market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion, and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Sialorrhea market data are presented with relevant tables and graphs to give a clear view of the market at first sight. According to DelveInsight, the Sialorrhea market in 7MM is expected to witness a major change in the study period 2019-2032.
Key Companies Working in the Sialorhhea Market
Merz Pharma
Proveca
And many others
Sialorhhea Therapies Covered and Analyzed in the Report
Hyoscine
Glycopyrrolate
Myobloc
Learn more about the Key Companies and Emerging Therapies in the Sialorhhea Market
Table of Contents
Key Insights
Sialorhhea Introduction
Executive Summary of Sialorrhea
Disease Background and Overview
Epidemiology and patient population
Sialorhhea Emerging Therapies
Market Access and Reimbursement of Therapies
Market Drivers
Market Barriers
Appendix
Report Methodology
DelveInsight Capabilities
Disclaimer
Learn about the detailed offerings of the report Sialorhhea Market Outlook
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Adya KaulEmail: Send EmailPhone: 919650213330Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/consulting/due-diligence-services
